GlassScriptPhysician profile
Terri L Tenhoor
NPI 1164491668
$8,166.07
in general payments reported to CMS, 2019-2025
42 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $834 · 2021: $873 · 2022: $997 · 2023: $1,520 · 2024: $1,840 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,604.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,012.12 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $877.28 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $821.52 | 2019-2025 | Ofev |
| Insmed, INC. | $509.71 | 2019-2025 | Arikayce |
| Grifols USA, LLC | $452.12 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $409.51 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $368.19 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $362.25 | 2019-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $348.61 | 2019-2025 | Winrevair, Belsomra |
| Baxter Healthcare | $257.22 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Jazz Pharmaceuticals INC. | $257.03 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $219.12 | 2019-2025 | |
| Harmony Biosciences LLC | $212.14 | 2020-2025 | Wakix |
| Sunovion Pharmaceuticals INC. | $174.33 | 2019-2021 | |
| United Therapeutics Corporation | $169.76 | 2021-2023 | Tyvaso |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $145.39 | 2023-2024 | Inspire |
| Ani Pharmaceuticals, INC. | $140.75 | 2023-2025 | Purified Cortrophin Gel |
| Electromed, INC. | $119.61 | 2019-2024 | Smartvest |
| Advanced Respiratory, INC | $114.72 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $111.77 | 2019-2023 | Airduo Digihaler |
| Philips North America LLC | $101.81 | 2020-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $97.86 | 2024-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $85.22 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $83.46 | 2020-2021 | |
| Amgen INC. | $71.11 | 2022-2024 | Tezspire |
| Mylan Specialty L.P. | $69.65 | 2022-2024 | Yupelri |
| Verona Pharma, INC. | $64.54 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $52.34 | 2019-2020 | |
| Inogen, INC. | $50.69 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vanda Pharmaceuticals INC. | $49.12 | 2022-2023 | Hetlioz |
| Abbvie INC. | $43.98 | 2021-2023 | Teflaro |
| Allergan, INC. | $42.55 | 2019-2020 | |
| Tactile Systems Technology INC | $41.76 | 2024 | Flexitouch Plus, Entre Plus |
| Johnson & Johnson Health Care Systems INC. | $36.47 | 2023 | Opsumit |
| Gilead Sciences, INC. | $30.75 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.71 | 2025 | Glassia |
| Melinta Therapeutics, LLC | $26.35 | 2023 | Vabomere |
| Idorsia Pharmaceuticals US INC | $24.63 | 2023 | Quviviq |
| Vapotherm INC | $22.20 | 2022 | |
| Phadia US INC. | $20.76 | 2023 | Immunocap |
| Novartis Pharmaceuticals Corporation | $20.69 | 2019 | |
| Lilly USA, LLC | $19.27 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Tenhoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.